187 related articles for article (PubMed ID: 2425956)
1. Hydroxyurea-induced conversion of mammalian ribonucleotide reductase to a form hypersensitive to bleomycin.
McClarty GA; Chan AK; Wright JA
Cancer Res; 1986 Sep; 46(9):4516-21. PubMed ID: 2425956
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of drug resistance involving ribonucleotide reductase: hydroxyurea resistance in a series of clonally related mouse cell lines selected in the presence of increasing drug concentrations.
Choy BK; McClarty GA; Chan AK; Thelander L; Wright JA
Cancer Res; 1988 Apr; 48(8):2029-35. PubMed ID: 2832057
[TBL] [Abstract][Full Text] [Related]
3. Mode of inhibition of tumor cell ribonucleotide reductase by 2,3-dihydro-1H-pyrazolo[2,3-a]imidazole (NSC 51143).
Cory JG; Fleischer AE
Cancer Res; 1980 Nov; 40(11):3891-4. PubMed ID: 6781737
[TBL] [Abstract][Full Text] [Related]
4. Cross-resistance patterns in hydroxyurea-resistant leukemia L1210 cells.
Carter GL; Cory JG
Cancer Res; 1988 Oct; 48(20):5796-9. PubMed ID: 2844392
[TBL] [Abstract][Full Text] [Related]
5. Characterization of mouse leukemia L1210 cells resistant to the ribonucleotide reductase inhibitor 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone.
Cory AH; Sato A; Thompson DP; Cory JG
Oncol Res; 1996; 8(10-11):449-56. PubMed ID: 9114437
[TBL] [Abstract][Full Text] [Related]
6. Ribonucleotide reduction in intact human diploid fibroblasts.
Dick JE; Wright JA
J Cell Physiol; 1980 Oct; 105(1):63-72. PubMed ID: 7000802
[TBL] [Abstract][Full Text] [Related]
7. Isolation and initial characterization of a series of Chlamydia trachomatis isolates selected for hydroxyurea resistance by a stepwise procedure.
Tipples G; McClarty G
J Bacteriol; 1991 Aug; 173(16):4932-40. PubMed ID: 1860812
[TBL] [Abstract][Full Text] [Related]
8. Effect of hydroxyurea on cellular iron metabolism in human leukemic CCRF-CEM cells: changes in iron uptake and the regulation of transferrin receptor and ferritin gene expression following inhibition of DNA synthesis.
Chitambar CR; Wereley JP
Cancer Res; 1995 Oct; 55(19):4361-6. PubMed ID: 7671248
[TBL] [Abstract][Full Text] [Related]
9. Unusual sensitivity to bleomycin and joint resistance to 9-beta-D-arabinofuranosyladenine and 1-beta-D-arabinofuranosylcytosine of mouse FM3A cell mutants with altered ribonucleotide reductase and thymidylate synthase.
Ayusawa D; Iwata K; Seno T
Cancer Res; 1983 Feb; 43(2):814-8. PubMed ID: 6184158
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of ribonucleotide reductase by gallium in murine leukemic L1210 cells.
Chitambar CR; Narasimhan J; Guy J; Sem DS; O'Brien WJ
Cancer Res; 1991 Nov; 51(22):6199-201. PubMed ID: 1933878
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of mammalian ribonucleotide reductase by a dinucleotide produced in eucaryotic cells.
Lewis WH; McNaughton DR; Goh SH; LéJohn HB; Wright JA
J Cell Physiol; 1977 Dec; 93(3):345-52. PubMed ID: 338619
[TBL] [Abstract][Full Text] [Related]
12. Ribonucleotide reductase from wild type and hydroxyurea-resistant chinese hamster ovary cells.
Lewis WH; Wright JA
J Cell Physiol; 1978 Oct; 97(1):87-97. PubMed ID: 568630
[TBL] [Abstract][Full Text] [Related]
13. M2 subunit of ribonucleotide reductase is a target of cyclic AMP-dependent protein kinase.
Albert DA; Nodzenski E
J Cell Physiol; 1989 Jan; 138(1):129-36. PubMed ID: 2536034
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of ribonucleotide reductase in transfected human KB cells increases their resistance to hydroxyurea: M2 but not M1 is sufficient to increase resistance to hydroxyurea in transfected cells.
Zhou BS; Hsu NY; Pan BC; Doroshow JH; Yen Y
Cancer Res; 1995 Mar; 55(6):1328-33. PubMed ID: 7882331
[TBL] [Abstract][Full Text] [Related]
15. Increased ribonucleotide reductase activity in hydroxyurea-resistant mosquito cells.
Gerenday A; Shih KM; Herman CC; Fallon AM
Arch Insect Biochem Physiol; 2001; 46(1-2):19-25. PubMed ID: 11276057
[TBL] [Abstract][Full Text] [Related]
16. Overproduction of the free radical of ribonucleotide reductase in hydroxyurea-resistant mouse fibroblast 3T6 cells.
Akerblom L; Ehrenberg A; Gräslund A; Lankinen H; Reichard P; Thelander L
Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2159-63. PubMed ID: 6264464
[TBL] [Abstract][Full Text] [Related]
17. Sensitization of P388 murine leukemia cells to hydroxyurea cytotoxicity by hydrophobic iron-chelating agents.
Satyamoorthy K; Chitnis M; Basrur V
Anticancer Res; 1986; 6(2):329-33. PubMed ID: 3518597
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of leukemic HL60 cell growth by transferrin-gallium: effects on ribonucleotide reductase and demonstration of drug synergy with hydroxyurea.
Chitambar CR; Matthaeus WG; Antholine WE; Graff K; O'Brien WJ
Blood; 1988 Dec; 72(6):1930-6. PubMed ID: 3058232
[TBL] [Abstract][Full Text] [Related]
19. Determination of the potency and subunit-selectivity of ribonucleotide reductase inhibitors with a recombinant-holoenzyme-based in vitro assay.
Shao J; Zhou B; Zhu L; Bilio AJ; Su L; Yuan YC; Ren S; Lien EJ; Shih J; Yen Y
Biochem Pharmacol; 2005 Feb; 69(4):627-34. PubMed ID: 15670581
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of malignant cell growth by 311, a novel iron chelator of the pyridoxal isonicotinoyl hydrazone class: effect on the R2 subunit of ribonucleotide reductase.
Green DA; Antholine WE; Wong SJ; Richardson DR; Chitambar CR
Clin Cancer Res; 2001 Nov; 7(11):3574-9. PubMed ID: 11705879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
